Head and Neck - Refresher 2020
Multidisciplinary management of head and neck cancers is essential to both understanding current treatment paradigms and tailoring treatment to the individual patient. Part of optimizing care is to understand how to intensify treatment in unfavorable cases while deescalating therapy in low risk cohorts. Numerous approaches testing different combinations of treatment modalities are under investigation. It is difficult to stay informed about what is standard of care or under active study. This course will review strategies to minimize radiation therapy toxicity that play a critical factor in maintaining quality of life and organ function preservation.
This activity is available from March 30, 2020, through 11:59 p.m. Eastern time on March 29, 2023.
This activity was originally recorded during ASTRO’s 2020 Annual Refresher Live Interactive Virtual Conference, March 20-22, 2020.
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.
- Describe how to minimize toxicity with improved understanding of OAR and tumor contouring.
- Discuss the need for incorporating other treatment modalities with RT to optimize oncologic outcomes.
- Outline current treatment paradigms and future clinical research directions.
Kenneth Hu, MD, FASTRO is employed by NYU Langone Medical Center and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
• No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
• No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
• ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.